Old Web
English
Sign In
Acemap
>
Paper
>
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease.
Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease.
2004
Petros P. Sfikakis
P. H. Kaklamanis
A. Elezoglou
N. Katsilambros
P. G. Theodossiadis
Semina Papaefthimiou
Nikos N. Markomichelakis
Keywords:
Dermatology
Diabetes mellitus
Infliximab
Adamantiades-Behcet disease
Internal medicine
Ocular inflammation
Medicine
Cardiology
Retinitis
Pharmacotherapy
Vasculitis
Ankylosing spondylitis
Cyclophosphamide
Correction
Source
Cite
Save
Machine Reading By IdeaReader
10
References
210
Citations
NaN
KQI
[]